TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 47 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $243,000 | -81.8% | 2,200 | -76.8% | 0.00% | -100.0% |
| Q1 2015 | $1,336,000 | -69.8% | 9,474 | -68.3% | 0.00% | -75.0% |
| Q4 2014 | $4,428,000 | -17.6% | 29,881 | -14.5% | 0.00% | -20.0% |
| Q3 2014 | $5,375,000 | -32.5% | 34,937 | -38.5% | 0.01% | -28.6% |
| Q2 2014 | $7,966,000 | +367.5% | 56,806 | +270.0% | 0.01% | +250.0% |
| Q1 2014 | $1,704,000 | +63.1% | 15,351 | +45.3% | 0.00% | +100.0% |
| Q4 2013 | $1,045,000 | +30.1% | 10,563 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $803,000 | – | 10,563 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 85,205 | $9,416,000 | 7.01% |
| FORT, L.P. | 149,014 | $16,468,000 | 5.67% |
| Strategic Global Advisors, LLC | 80,231 | $11,336,000 | 4.23% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 701,900 | $77,567,000 | 3.19% |
| Ativo Capital Management LLC | 78,727 | $8,700,000 | 2.01% |
| Analyst IMS Investment Management Services Ltd. | 31,438 | $3,474,000 | 1.47% |
| Parametrica Management Ltd | 4,327 | $478,000 | 1.32% |
| Freestone Capital Holdings, LLC | 89,005 | $9,836,000 | 0.90% |
| RPG Investment Advisory, LLC | 19,580 | $2,163,000 | 0.68% |
| MERITAGE PORTFOLIO MANAGEMENT | 38,465 | $4,251,000 | 0.47% |